検索結果 12 件

Aurore Perrot, Valerie Lauwers-Cances, Titouan Cazaubiel, Thierry Facon, Denis Caillot, Lauriane Clement-Filliatre, Margaret Macro, Olivier Decaux, Karim Belhadj, Mohamad Mohty, Lionel Karlin, Jean Claude Eisenmann, Mourad Tiab, Frederique Orsini, Cyrille Touzeau, Xavier Leleu, Herve Avet-Loiseau, Nikhil C. Munshi, Kenneth Anderson, Paul G. Richardson, Philippe Moreau, Michel Attal Blood 136 (Supplement 1), 39-39, 2020-11-05

...Among these pts, 76.7% (201/262) in RG and 22.6% (49/217) in TG received an ASCT at 1st relapse; 40.1% (105/262) and 46.5% (101/217) respectively received a pomalidomide-based 2nd line....

DOI Web Site 被引用文献2件

Michael J. Overman, Sara Lonardi, Ka Yeung Mark Wong, Heinz-Josef Lenz, Fabio Gelsomino, Massimo Aglietta, Michael Morse, Eric Van Cutsem, Raymond S. McDermott, Andrew G Hill, Michael B. Sawyer, Alain Hendlisz, Bart Neyns, Magali Svrcek, Ajlan Atasoy, Huanyu Zhao, Ming Lei, Scott Kopetz, Thierry Andre Journal of Clinical Oncology 37 (4_suppl), 635-635, 2019-02-01

...Results: Of 119 treated pts, 76% had ≥ 2 prior lines of therapy. ORR and disease control rates (DCR) were 58 and 81%, respectively (Table)....

DOI Web Site 被引用文献3件

H Kawaguchi, T Yamashita, N Masuda, M Kitada, K Narui, M Hattori, T Yoshinami, N Matsunami, K Yanagihara, T Kawasoe, T Nagashima, H Bando, H Yano, Y Hasegawa, R Nakamura, M Kashiwaba, S Morita, S Ohno, M Toi Cancer Research 78 (4_Supplement), 2018-02-15

...Eleven pts (23.9%) were de-novo Stage 4, and 35 pts (76.1%) had progressed in metastatic disease after completion of local therapy....

DOI Web Site 被引用文献1件

Thierry Andre, Sara Lonardi, Mark Wong, Heinz-Josef Lenz, Fabio Gelsomino, Massimo Aglietta, Michael Morse, Eric Van Cutsem, Raymond S. McDermott, Andrew G Hill, Michael B. Sawyer, Alain Hendlisz, Bart Neyns, Magali Svrcek, Rebecca Anne Moss, Jean-Marie Ledeine, Z. Alexander Cao, Shital Kamble, Scott Kopetz, Michael J. Overman Journal of Clinical Oncology 36 (4_suppl), 553-553, 2018-02-01

...Results: Of 119 treated pts, 76% had ≥ 2 prior lines of therapy. Median follow-up was 13.4 mo. The ORR was 55% and DCR was 80% (Table). Notably, ORR in pts with a BRAF mutation was 55%....

DOI Web Site 被引用文献2件

Martin Griesshammer, Alessandro M. Vannucchi, Philipp le Coutre, Renato S Tavares, Haifa Kathrin Al-Ali, Pia Raanani, Vikas Gupta, Lynda M Foltz, Pilar Giraldo, Catherine Bouard, Julian Perez Ronco, Jagannath Ghosh, Bruno Martino Blood 124 (21), 1859-1859, 2014-12-06

...Most pts (76.0%) remained on or completed treatment as per protocol at the time of data cutoff....

DOI Web Site 被引用文献1件

蛭間 基夫, 鈴木 浩, 中島 明子 理学療法学Supplement 2011 (0), Ea0361-Ea0361, 2012

...【結果】　(1)本調査の対象者の概要として両協会が発行している白書と比較すると，回答者の勤務先，性別，年齢は同傾向を示していた．(2)住宅改善の介入経験があるのはPT76.1%，OT67.5%であった．(3)介入した対象者として「自分が直接担当した者」(PT98.0%，OT96.6%)が各々最多であった．(4)具体的な介入場面としては「工事前の動作・ADLの評価」(PT94.2%，OT91.3%)，...

DOI

四方田 千佳子, 松田 りえ子, 荒木 惠美子, 山田 明子, 大河原 正光, 中澤 裕之, 松木 容彦, 松本 年雄, 森 曜子, 安井 明美, 高田 芳矩, 福原 克治, 大島 赴夫, 花形 吾朗, 小野 昭紘, 柿田 和俊, 瀧本 憲一, 坂田 衞 分析化学 58 (11), 963-970, 2009

...The ratios of laboratories evaluated as being satisfactory, or | <i>z</i> |≤2, were 79∼91% in 1st PT, 76∼96% in 2nd PT, 74∼90% in 3rd PT and 83∼86% in 4th PT, depending on the constituents....

DOI Web Site Web Site 参考文献26件

Hirohiko Kuratsune, Etsuji Suehisa, Teruo Kitani, Yoshinori Iwatani, Yuzuru Kanakura, Junzo Nojima Thrombosis and Haemostasis 91 (05), 967-976, 2004

...The prevalence of cerebral infarction was obviously higher in the patients who had both anti-CL/β2-GPI and anti-PS/PT (76.5% [26/34 cases], p<0.0001) than in the other patients having antiCL/β2-GPI or...

DOI PDF 被引用文献5件

吉田 肇, 金子 武次郎, 阿部 峻也, 高梨 弘毅, 藤森 啓安 日本物理学会講演概要集 53.2.3 (0), 468-, 1998

DOI

吉田 肇, 金子 武次郎, 阿部 竣也, 藤森 啓安, 太田 悟 日本物理学会講演概要集 52.2.3 (0), 454-, 1997

DOI

B Wallace, Y J Yang, J S Hong, D Lum Journal of Bacteriology 172 (6), 3214-3220, 1990-06

...A 1.6-kilobase DNA fragment containing gltP was subcloned into the expression plasmids pT7-5 and pT7-6, and its product was identified by a phage T7 RNA polymerase-T7 promoter coupled system (S....

DOI Web Site 被引用文献1件

高橋 酉蔵, 神代 昭 ＣＨＥＭＩＣＡＬ　＆　ＰＨＡＲＭＡＣＥＵＴＩＣＡＬ　ＢＵＬＬＥＴＩＮ 9 (6), 426-432, 1961

1) 7-Substituted 2-methyl- or 2-phenyl-oxazolo [4, 5-c] pyridines were prepared from 3, 5-dinitro-4-hydroxypyridine and some of them were hydrogenated over palladium-carbon or Raney nickel. 2) By …

DOI Web Site Web Site ほか1件